Pfizer’s Omicron-Adapted Candidate Vaccines Show Positive Results 27/06/2022 Maayan Hoffman Pfizer and BioNTech have announced positive safety, tolerability and immunogenicity data for two Omicron-adapted COVID-19 mRNA candidate vaccines – but for an earlier strain of Omicron than those that are currently globally dominant. The two Omicron-adapted vaccine candidates were given to 1,234 participants aged 56 years and older as boosters, and “elicited substantially higher neutralizing […] Continue reading -> Children Have Strong Immunity Against COVID-19 Up to 18 Months After Being Infected 24/06/2022 Maayan Hoffman Children infected with COVID-19 maintained strong immunity against the virus for at least 18 months, according to a preprint study that was released on Wednesday. The study, which has not yet been peer-reviewed, was conducted by Kahn-Sagol-Maccabi (KSM), the research and innovation center of Maccabi Healthcare Services in Israel, and was released on the preprint server […] Continue reading -> COVID-19 Vaccines Saved Almost 20 Million Lives in a Year, Modelling Study Estimates 24/06/2022 Kerry Cullinan COVID-19 vaccines prevented almost 20 million deaths worldwide in the first year of the vaccine programme, according to a modelling study published in The Lancet on Friday. The first modelling study to quantify the global impact of COVID-19 vaccines estimates that 19.8 million out of a potential 31.4 million deaths were prevented in the first […] Continue reading -> How Scientists in Botswana Discovered Omicron: A Look at Diagnostics in LMICs 23/06/2022 Maayan Hoffman The Global Health Matters podcast with host Garry Aslanyan. It was 11 November 2022 when Dr Sikhulile Moyo and his team of scientists in Botswana discovered Omicron in a sample of SARS-CoV2 that looked different from the rest. “We sent it back to the lab to have it re-sequenced,” Moyo recalled. But by 19 November, […] Continue reading -> Biotech Companies’ Agreement Paves Way for First African-Owned COVID-19 Vaccine 21/06/2022 Raisa Santos One year since the establishment of the mRNA Vaccine Technology Transfer Hub, a collaboration between two leading biotech companies – Afrigen Biologics and the Univercells group – was announced on Tuesday, paving the way for the development of the first-ever African-owned COVID-19 vaccine through open-access intellectual property. Using intellectual property from partners, the collaboration between […] Continue reading -> The Fuss Over Who Should Declare Public Health Emergencies in Africa 20/06/2022 Paul Adepoju Africa CDC wants to be able to declare public health emergencies of continental security but the WHO warns this could be a risky move that could isolate African countries and create confusion regarding response. The World Health Organization’s African Regional Office (WHO AFRO) has found itself explaining its disapproval of the Africa CDC’s quest for […] Continue reading -> Spanish COVID-19 Antibody Test to be Manufactured by Biotech Africa Under Open License Agreement with WHO’s C-TAP 16/06/2022 Raisa Santos A new sublicense agreement for a COVID-19 antibody test has been announced Thursday by the Medicines Patent Pool (MPP) on behalf of the World Health Organization’s COVID-19 Technology Access Pool (C-TAP) and South African company Biotech Africa. The new agreement builds on the first non-exclusive licensing agreement announced by WHO and MPP last year with […] Continue reading -> WTO Ministerial Conference Extended for Another Day as Pressure Builds for Results 15/06/2022 John Heilprin & Elaine Ruth Fletcher The World Trade Organization (WTO) is extending its 12th Ministerial Conference (MC12) for a fifth day, buying time for delegates to negotiate some tough deals in five main areas: the pandemic response, COVID-19 vaccines, fishing subsidies, food shortages and agriculture. The long-delayed ministerial conference, which opened on Sunday and was originally planned to close on […] Continue reading -> Pyrrhic Victory if WTO Agrees to Patent Waiver for COVID-19 Vaccines 14/06/2022 Elaine Ruth Fletcher After nearly 18 months of debate, World Trade Organization (WTO) members now appear likely to approve a limited waiver of patent rights on COVID-19 vaccines in their closing session on Wednesday. But if the current draft text is approved as it stands, it may be a pyrrhic victory for the medicines access groups that fought […] Continue reading -> New WHO Report Affirms Need to Study SARS-CoV2 Lab Leak Theory – Alongside Spillover Narrative 10/06/2022 Elaine Ruth Fletcher The first report by the new WHO-convened expert group, Scientific Advisory Group for the Origins of Novel Pathogens (SAGO) has fanned the flames of controversy over evidence about whether a lab leak or a natural “spillover” of the virus from animals to humans was the most likely source from which the COVID pandemic emerged – […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Children Have Strong Immunity Against COVID-19 Up to 18 Months After Being Infected 24/06/2022 Maayan Hoffman Children infected with COVID-19 maintained strong immunity against the virus for at least 18 months, according to a preprint study that was released on Wednesday. The study, which has not yet been peer-reviewed, was conducted by Kahn-Sagol-Maccabi (KSM), the research and innovation center of Maccabi Healthcare Services in Israel, and was released on the preprint server […] Continue reading -> COVID-19 Vaccines Saved Almost 20 Million Lives in a Year, Modelling Study Estimates 24/06/2022 Kerry Cullinan COVID-19 vaccines prevented almost 20 million deaths worldwide in the first year of the vaccine programme, according to a modelling study published in The Lancet on Friday. The first modelling study to quantify the global impact of COVID-19 vaccines estimates that 19.8 million out of a potential 31.4 million deaths were prevented in the first […] Continue reading -> How Scientists in Botswana Discovered Omicron: A Look at Diagnostics in LMICs 23/06/2022 Maayan Hoffman The Global Health Matters podcast with host Garry Aslanyan. It was 11 November 2022 when Dr Sikhulile Moyo and his team of scientists in Botswana discovered Omicron in a sample of SARS-CoV2 that looked different from the rest. “We sent it back to the lab to have it re-sequenced,” Moyo recalled. But by 19 November, […] Continue reading -> Biotech Companies’ Agreement Paves Way for First African-Owned COVID-19 Vaccine 21/06/2022 Raisa Santos One year since the establishment of the mRNA Vaccine Technology Transfer Hub, a collaboration between two leading biotech companies – Afrigen Biologics and the Univercells group – was announced on Tuesday, paving the way for the development of the first-ever African-owned COVID-19 vaccine through open-access intellectual property. Using intellectual property from partners, the collaboration between […] Continue reading -> The Fuss Over Who Should Declare Public Health Emergencies in Africa 20/06/2022 Paul Adepoju Africa CDC wants to be able to declare public health emergencies of continental security but the WHO warns this could be a risky move that could isolate African countries and create confusion regarding response. The World Health Organization’s African Regional Office (WHO AFRO) has found itself explaining its disapproval of the Africa CDC’s quest for […] Continue reading -> Spanish COVID-19 Antibody Test to be Manufactured by Biotech Africa Under Open License Agreement with WHO’s C-TAP 16/06/2022 Raisa Santos A new sublicense agreement for a COVID-19 antibody test has been announced Thursday by the Medicines Patent Pool (MPP) on behalf of the World Health Organization’s COVID-19 Technology Access Pool (C-TAP) and South African company Biotech Africa. The new agreement builds on the first non-exclusive licensing agreement announced by WHO and MPP last year with […] Continue reading -> WTO Ministerial Conference Extended for Another Day as Pressure Builds for Results 15/06/2022 John Heilprin & Elaine Ruth Fletcher The World Trade Organization (WTO) is extending its 12th Ministerial Conference (MC12) for a fifth day, buying time for delegates to negotiate some tough deals in five main areas: the pandemic response, COVID-19 vaccines, fishing subsidies, food shortages and agriculture. The long-delayed ministerial conference, which opened on Sunday and was originally planned to close on […] Continue reading -> Pyrrhic Victory if WTO Agrees to Patent Waiver for COVID-19 Vaccines 14/06/2022 Elaine Ruth Fletcher After nearly 18 months of debate, World Trade Organization (WTO) members now appear likely to approve a limited waiver of patent rights on COVID-19 vaccines in their closing session on Wednesday. But if the current draft text is approved as it stands, it may be a pyrrhic victory for the medicines access groups that fought […] Continue reading -> New WHO Report Affirms Need to Study SARS-CoV2 Lab Leak Theory – Alongside Spillover Narrative 10/06/2022 Elaine Ruth Fletcher The first report by the new WHO-convened expert group, Scientific Advisory Group for the Origins of Novel Pathogens (SAGO) has fanned the flames of controversy over evidence about whether a lab leak or a natural “spillover” of the virus from animals to humans was the most likely source from which the COVID pandemic emerged – […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
COVID-19 Vaccines Saved Almost 20 Million Lives in a Year, Modelling Study Estimates 24/06/2022 Kerry Cullinan COVID-19 vaccines prevented almost 20 million deaths worldwide in the first year of the vaccine programme, according to a modelling study published in The Lancet on Friday. The first modelling study to quantify the global impact of COVID-19 vaccines estimates that 19.8 million out of a potential 31.4 million deaths were prevented in the first […] Continue reading -> How Scientists in Botswana Discovered Omicron: A Look at Diagnostics in LMICs 23/06/2022 Maayan Hoffman The Global Health Matters podcast with host Garry Aslanyan. It was 11 November 2022 when Dr Sikhulile Moyo and his team of scientists in Botswana discovered Omicron in a sample of SARS-CoV2 that looked different from the rest. “We sent it back to the lab to have it re-sequenced,” Moyo recalled. But by 19 November, […] Continue reading -> Biotech Companies’ Agreement Paves Way for First African-Owned COVID-19 Vaccine 21/06/2022 Raisa Santos One year since the establishment of the mRNA Vaccine Technology Transfer Hub, a collaboration between two leading biotech companies – Afrigen Biologics and the Univercells group – was announced on Tuesday, paving the way for the development of the first-ever African-owned COVID-19 vaccine through open-access intellectual property. Using intellectual property from partners, the collaboration between […] Continue reading -> The Fuss Over Who Should Declare Public Health Emergencies in Africa 20/06/2022 Paul Adepoju Africa CDC wants to be able to declare public health emergencies of continental security but the WHO warns this could be a risky move that could isolate African countries and create confusion regarding response. The World Health Organization’s African Regional Office (WHO AFRO) has found itself explaining its disapproval of the Africa CDC’s quest for […] Continue reading -> Spanish COVID-19 Antibody Test to be Manufactured by Biotech Africa Under Open License Agreement with WHO’s C-TAP 16/06/2022 Raisa Santos A new sublicense agreement for a COVID-19 antibody test has been announced Thursday by the Medicines Patent Pool (MPP) on behalf of the World Health Organization’s COVID-19 Technology Access Pool (C-TAP) and South African company Biotech Africa. The new agreement builds on the first non-exclusive licensing agreement announced by WHO and MPP last year with […] Continue reading -> WTO Ministerial Conference Extended for Another Day as Pressure Builds for Results 15/06/2022 John Heilprin & Elaine Ruth Fletcher The World Trade Organization (WTO) is extending its 12th Ministerial Conference (MC12) for a fifth day, buying time for delegates to negotiate some tough deals in five main areas: the pandemic response, COVID-19 vaccines, fishing subsidies, food shortages and agriculture. The long-delayed ministerial conference, which opened on Sunday and was originally planned to close on […] Continue reading -> Pyrrhic Victory if WTO Agrees to Patent Waiver for COVID-19 Vaccines 14/06/2022 Elaine Ruth Fletcher After nearly 18 months of debate, World Trade Organization (WTO) members now appear likely to approve a limited waiver of patent rights on COVID-19 vaccines in their closing session on Wednesday. But if the current draft text is approved as it stands, it may be a pyrrhic victory for the medicines access groups that fought […] Continue reading -> New WHO Report Affirms Need to Study SARS-CoV2 Lab Leak Theory – Alongside Spillover Narrative 10/06/2022 Elaine Ruth Fletcher The first report by the new WHO-convened expert group, Scientific Advisory Group for the Origins of Novel Pathogens (SAGO) has fanned the flames of controversy over evidence about whether a lab leak or a natural “spillover” of the virus from animals to humans was the most likely source from which the COVID pandemic emerged – […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
How Scientists in Botswana Discovered Omicron: A Look at Diagnostics in LMICs 23/06/2022 Maayan Hoffman The Global Health Matters podcast with host Garry Aslanyan. It was 11 November 2022 when Dr Sikhulile Moyo and his team of scientists in Botswana discovered Omicron in a sample of SARS-CoV2 that looked different from the rest. “We sent it back to the lab to have it re-sequenced,” Moyo recalled. But by 19 November, […] Continue reading -> Biotech Companies’ Agreement Paves Way for First African-Owned COVID-19 Vaccine 21/06/2022 Raisa Santos One year since the establishment of the mRNA Vaccine Technology Transfer Hub, a collaboration between two leading biotech companies – Afrigen Biologics and the Univercells group – was announced on Tuesday, paving the way for the development of the first-ever African-owned COVID-19 vaccine through open-access intellectual property. Using intellectual property from partners, the collaboration between […] Continue reading -> The Fuss Over Who Should Declare Public Health Emergencies in Africa 20/06/2022 Paul Adepoju Africa CDC wants to be able to declare public health emergencies of continental security but the WHO warns this could be a risky move that could isolate African countries and create confusion regarding response. The World Health Organization’s African Regional Office (WHO AFRO) has found itself explaining its disapproval of the Africa CDC’s quest for […] Continue reading -> Spanish COVID-19 Antibody Test to be Manufactured by Biotech Africa Under Open License Agreement with WHO’s C-TAP 16/06/2022 Raisa Santos A new sublicense agreement for a COVID-19 antibody test has been announced Thursday by the Medicines Patent Pool (MPP) on behalf of the World Health Organization’s COVID-19 Technology Access Pool (C-TAP) and South African company Biotech Africa. The new agreement builds on the first non-exclusive licensing agreement announced by WHO and MPP last year with […] Continue reading -> WTO Ministerial Conference Extended for Another Day as Pressure Builds for Results 15/06/2022 John Heilprin & Elaine Ruth Fletcher The World Trade Organization (WTO) is extending its 12th Ministerial Conference (MC12) for a fifth day, buying time for delegates to negotiate some tough deals in five main areas: the pandemic response, COVID-19 vaccines, fishing subsidies, food shortages and agriculture. The long-delayed ministerial conference, which opened on Sunday and was originally planned to close on […] Continue reading -> Pyrrhic Victory if WTO Agrees to Patent Waiver for COVID-19 Vaccines 14/06/2022 Elaine Ruth Fletcher After nearly 18 months of debate, World Trade Organization (WTO) members now appear likely to approve a limited waiver of patent rights on COVID-19 vaccines in their closing session on Wednesday. But if the current draft text is approved as it stands, it may be a pyrrhic victory for the medicines access groups that fought […] Continue reading -> New WHO Report Affirms Need to Study SARS-CoV2 Lab Leak Theory – Alongside Spillover Narrative 10/06/2022 Elaine Ruth Fletcher The first report by the new WHO-convened expert group, Scientific Advisory Group for the Origins of Novel Pathogens (SAGO) has fanned the flames of controversy over evidence about whether a lab leak or a natural “spillover” of the virus from animals to humans was the most likely source from which the COVID pandemic emerged – […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Biotech Companies’ Agreement Paves Way for First African-Owned COVID-19 Vaccine 21/06/2022 Raisa Santos One year since the establishment of the mRNA Vaccine Technology Transfer Hub, a collaboration between two leading biotech companies – Afrigen Biologics and the Univercells group – was announced on Tuesday, paving the way for the development of the first-ever African-owned COVID-19 vaccine through open-access intellectual property. Using intellectual property from partners, the collaboration between […] Continue reading -> The Fuss Over Who Should Declare Public Health Emergencies in Africa 20/06/2022 Paul Adepoju Africa CDC wants to be able to declare public health emergencies of continental security but the WHO warns this could be a risky move that could isolate African countries and create confusion regarding response. The World Health Organization’s African Regional Office (WHO AFRO) has found itself explaining its disapproval of the Africa CDC’s quest for […] Continue reading -> Spanish COVID-19 Antibody Test to be Manufactured by Biotech Africa Under Open License Agreement with WHO’s C-TAP 16/06/2022 Raisa Santos A new sublicense agreement for a COVID-19 antibody test has been announced Thursday by the Medicines Patent Pool (MPP) on behalf of the World Health Organization’s COVID-19 Technology Access Pool (C-TAP) and South African company Biotech Africa. The new agreement builds on the first non-exclusive licensing agreement announced by WHO and MPP last year with […] Continue reading -> WTO Ministerial Conference Extended for Another Day as Pressure Builds for Results 15/06/2022 John Heilprin & Elaine Ruth Fletcher The World Trade Organization (WTO) is extending its 12th Ministerial Conference (MC12) for a fifth day, buying time for delegates to negotiate some tough deals in five main areas: the pandemic response, COVID-19 vaccines, fishing subsidies, food shortages and agriculture. The long-delayed ministerial conference, which opened on Sunday and was originally planned to close on […] Continue reading -> Pyrrhic Victory if WTO Agrees to Patent Waiver for COVID-19 Vaccines 14/06/2022 Elaine Ruth Fletcher After nearly 18 months of debate, World Trade Organization (WTO) members now appear likely to approve a limited waiver of patent rights on COVID-19 vaccines in their closing session on Wednesday. But if the current draft text is approved as it stands, it may be a pyrrhic victory for the medicines access groups that fought […] Continue reading -> New WHO Report Affirms Need to Study SARS-CoV2 Lab Leak Theory – Alongside Spillover Narrative 10/06/2022 Elaine Ruth Fletcher The first report by the new WHO-convened expert group, Scientific Advisory Group for the Origins of Novel Pathogens (SAGO) has fanned the flames of controversy over evidence about whether a lab leak or a natural “spillover” of the virus from animals to humans was the most likely source from which the COVID pandemic emerged – […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
The Fuss Over Who Should Declare Public Health Emergencies in Africa 20/06/2022 Paul Adepoju Africa CDC wants to be able to declare public health emergencies of continental security but the WHO warns this could be a risky move that could isolate African countries and create confusion regarding response. The World Health Organization’s African Regional Office (WHO AFRO) has found itself explaining its disapproval of the Africa CDC’s quest for […] Continue reading -> Spanish COVID-19 Antibody Test to be Manufactured by Biotech Africa Under Open License Agreement with WHO’s C-TAP 16/06/2022 Raisa Santos A new sublicense agreement for a COVID-19 antibody test has been announced Thursday by the Medicines Patent Pool (MPP) on behalf of the World Health Organization’s COVID-19 Technology Access Pool (C-TAP) and South African company Biotech Africa. The new agreement builds on the first non-exclusive licensing agreement announced by WHO and MPP last year with […] Continue reading -> WTO Ministerial Conference Extended for Another Day as Pressure Builds for Results 15/06/2022 John Heilprin & Elaine Ruth Fletcher The World Trade Organization (WTO) is extending its 12th Ministerial Conference (MC12) for a fifth day, buying time for delegates to negotiate some tough deals in five main areas: the pandemic response, COVID-19 vaccines, fishing subsidies, food shortages and agriculture. The long-delayed ministerial conference, which opened on Sunday and was originally planned to close on […] Continue reading -> Pyrrhic Victory if WTO Agrees to Patent Waiver for COVID-19 Vaccines 14/06/2022 Elaine Ruth Fletcher After nearly 18 months of debate, World Trade Organization (WTO) members now appear likely to approve a limited waiver of patent rights on COVID-19 vaccines in their closing session on Wednesday. But if the current draft text is approved as it stands, it may be a pyrrhic victory for the medicines access groups that fought […] Continue reading -> New WHO Report Affirms Need to Study SARS-CoV2 Lab Leak Theory – Alongside Spillover Narrative 10/06/2022 Elaine Ruth Fletcher The first report by the new WHO-convened expert group, Scientific Advisory Group for the Origins of Novel Pathogens (SAGO) has fanned the flames of controversy over evidence about whether a lab leak or a natural “spillover” of the virus from animals to humans was the most likely source from which the COVID pandemic emerged – […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Spanish COVID-19 Antibody Test to be Manufactured by Biotech Africa Under Open License Agreement with WHO’s C-TAP 16/06/2022 Raisa Santos A new sublicense agreement for a COVID-19 antibody test has been announced Thursday by the Medicines Patent Pool (MPP) on behalf of the World Health Organization’s COVID-19 Technology Access Pool (C-TAP) and South African company Biotech Africa. The new agreement builds on the first non-exclusive licensing agreement announced by WHO and MPP last year with […] Continue reading -> WTO Ministerial Conference Extended for Another Day as Pressure Builds for Results 15/06/2022 John Heilprin & Elaine Ruth Fletcher The World Trade Organization (WTO) is extending its 12th Ministerial Conference (MC12) for a fifth day, buying time for delegates to negotiate some tough deals in five main areas: the pandemic response, COVID-19 vaccines, fishing subsidies, food shortages and agriculture. The long-delayed ministerial conference, which opened on Sunday and was originally planned to close on […] Continue reading -> Pyrrhic Victory if WTO Agrees to Patent Waiver for COVID-19 Vaccines 14/06/2022 Elaine Ruth Fletcher After nearly 18 months of debate, World Trade Organization (WTO) members now appear likely to approve a limited waiver of patent rights on COVID-19 vaccines in their closing session on Wednesday. But if the current draft text is approved as it stands, it may be a pyrrhic victory for the medicines access groups that fought […] Continue reading -> New WHO Report Affirms Need to Study SARS-CoV2 Lab Leak Theory – Alongside Spillover Narrative 10/06/2022 Elaine Ruth Fletcher The first report by the new WHO-convened expert group, Scientific Advisory Group for the Origins of Novel Pathogens (SAGO) has fanned the flames of controversy over evidence about whether a lab leak or a natural “spillover” of the virus from animals to humans was the most likely source from which the COVID pandemic emerged – […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WTO Ministerial Conference Extended for Another Day as Pressure Builds for Results 15/06/2022 John Heilprin & Elaine Ruth Fletcher The World Trade Organization (WTO) is extending its 12th Ministerial Conference (MC12) for a fifth day, buying time for delegates to negotiate some tough deals in five main areas: the pandemic response, COVID-19 vaccines, fishing subsidies, food shortages and agriculture. The long-delayed ministerial conference, which opened on Sunday and was originally planned to close on […] Continue reading -> Pyrrhic Victory if WTO Agrees to Patent Waiver for COVID-19 Vaccines 14/06/2022 Elaine Ruth Fletcher After nearly 18 months of debate, World Trade Organization (WTO) members now appear likely to approve a limited waiver of patent rights on COVID-19 vaccines in their closing session on Wednesday. But if the current draft text is approved as it stands, it may be a pyrrhic victory for the medicines access groups that fought […] Continue reading -> New WHO Report Affirms Need to Study SARS-CoV2 Lab Leak Theory – Alongside Spillover Narrative 10/06/2022 Elaine Ruth Fletcher The first report by the new WHO-convened expert group, Scientific Advisory Group for the Origins of Novel Pathogens (SAGO) has fanned the flames of controversy over evidence about whether a lab leak or a natural “spillover” of the virus from animals to humans was the most likely source from which the COVID pandemic emerged – […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Pyrrhic Victory if WTO Agrees to Patent Waiver for COVID-19 Vaccines 14/06/2022 Elaine Ruth Fletcher After nearly 18 months of debate, World Trade Organization (WTO) members now appear likely to approve a limited waiver of patent rights on COVID-19 vaccines in their closing session on Wednesday. But if the current draft text is approved as it stands, it may be a pyrrhic victory for the medicines access groups that fought […] Continue reading -> New WHO Report Affirms Need to Study SARS-CoV2 Lab Leak Theory – Alongside Spillover Narrative 10/06/2022 Elaine Ruth Fletcher The first report by the new WHO-convened expert group, Scientific Advisory Group for the Origins of Novel Pathogens (SAGO) has fanned the flames of controversy over evidence about whether a lab leak or a natural “spillover” of the virus from animals to humans was the most likely source from which the COVID pandemic emerged – […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
New WHO Report Affirms Need to Study SARS-CoV2 Lab Leak Theory – Alongside Spillover Narrative 10/06/2022 Elaine Ruth Fletcher The first report by the new WHO-convened expert group, Scientific Advisory Group for the Origins of Novel Pathogens (SAGO) has fanned the flames of controversy over evidence about whether a lab leak or a natural “spillover” of the virus from animals to humans was the most likely source from which the COVID pandemic emerged – […] Continue reading -> Posts navigation Older postsNewer posts